Surrogate marker in clinical studies with anti-angiogenic drugs.

International journal of clinical pharmacology and therapeutics

Volumn 41, Issue 12, 2003, Pages 600-602

  Zirrgiebel, U ^a   Drevs, J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BIOLOGICAL MARKER;

BIOASSAY; HUMAN; NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 1 CLINICAL TRIAL; REVIEW; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; BIOLOGICAL MARKERS; CLINICAL TRIALS, PHASE I; ENDPOINT DETERMINATION; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASMS;

EID: 1542542078     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: 10.5414/CPP41600     Document Type: Review

References (7)